Skip to content
Home / Companies / VKTX VKT
Viking Therapeutics, Inc. (VKTX) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest VKTX Insider Trades
About Viking Therapeutics, Inc. (VKTX) Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Headquarters SAN DIEGO, CA
Employees 65
Listed 2015
Exchange XNAS https://www.vikingtherapeutics.com SEC filings for VKTX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 3 187,951 $6.27M Grant or award 6 522,134
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
VKTX Insider Transactions (Form 4) 91 27 Form 4 filings on record, the earliest from Oct 25, 2024, newest first.
Date Insider Transaction Security Shares Price Value Aug 1, 2026 DK Dorothy Elizabeth Kelly-Gemmell - Director Grant or award Common Stock, par value $0.00001 per share
Recent VKTX Form 8-K Filings 3
Recent VKTX Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jul 29, 2026 - - - - View on EDGAR Jul 29, 2026 - - -
VKTX Insider Trading - FAQ
What is the latest insider trade for VKTX? Viking Therapeutics, Inc. (VKTX) had 5 insider filings in the last 90 days, with the most recent on 2026-08-07. The full record for VKTX runs to 27 Form 4 filings, the earliest from 2024-10-25. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying VKTX stock? No insider purchases of VKTX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling VKTX stock? 3 insider sales of VKTX were filed in the last 90 days, totaling $6.27M.
Where can I see VKTX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks VKTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow VKTX insider buys? Create a free InsiderAlpha account and press Watch on this page to add VKTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track VKTX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $710K
GZ Greg Zante - Officer Open-market sale $1.03M
Jan 5, 2026
GZ Greg Zante - Officer Open-market sale $464K
Jan 5, 2026
GZ Greg Zante - Officer Open-market sale $353K
Jan 5, 2026
GZ Greg Zante - Officer Open-market sale $48K
Jan 5, 2026
Market cap $3.75B
P/E ratio -
Dividend yield -
Average volume 2.25M
52 week high $43.15
52 week low $22.96
Today's high $33.86
Today's low $31.98
Open $33.75
Volume 2.38M
Previous close $33.86
Shares outstanding 116.65M Market cap
$3.75B
65 employees
VKTX Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 3 sales totaling $6.27M.
Most-Active VKTX Insiders - Last 90 Days 10 Jul 28, 2026 BL Brian Lian - Officer Grant or award Common Stock, par value $0.00001 per share 221,667 $0.00 -
Jul 29, 2026 BL Brian Lian - Officer Open-market sale Common Stock, par value $0.00001 per share 148,517 $33.32 $4.95M
Jul 28, 2026 GZ Greg Zante - Officer Grant or award Common Stock, par value $0.00001 per share 31,667 $0.00 -
Jul 29, 2026 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 21,217 $33.47 $710K
Jul 28, 2026 MM Marianna Mancini - Officer Grant or award Common Stock, par value $0.00001 per share 31,667 $0.00 -
Jul 29, 2026 MM Marianna Mancini - Officer Open-market sale Common Stock, par value $0.00001 per share 18,217 $33.47 $610K
Jun 1, 2026 HC Hubert C. Chen - Officer Grant or award Stock Option (Right to Buy) 190,000 $0.00 -
Mar 10, 2026 NA Neil William Aubuchon - Officer Open-market purchase Common Stock, par value $0.00001 per share 4,475 $33.50 $150K
Jan 2, 2026 GZ Greg Zante - Officer Grant or award Common Stock, par value $0.00001 per share 41,000 $0.00 -
Jan 2, 2026 GZ Greg Zante - Officer Grant or award Common Stock, par value $0.00001 per share 32,049 $0.00 -
Jan 5, 2026 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 31,961 $32.30 $1.03M
Jan 5, 2026 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 13,900 $33.38 $464K
Jan 5, 2026 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 10,300 $34.24 $353K
Jan 5, 2026 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 1,500 $32.09 $48K
Jan 2, 2026 GZ Greg Zante - Officer Grant or award Stock Option (Right to Buy) 91,000 $0.00 -
Jan 2, 2026 MM Marianna Mancini - Officer Grant or award Common Stock, par value $0.00001 per share 41,000 $0.00 -
Jan 2, 2026 MM Marianna Mancini - Officer Grant or award Common Stock, par value $0.00001 per share 32,049 $0.00 -
Jan 5, 2026 MM Marianna Mancini - Officer Open-market sale Common Stock, par value $0.00001 per share 31,961 $32.29 $1.03M
Jan 5, 2026 MM Marianna Mancini - Officer Open-market sale Common Stock, par value $0.00001 per share 13,600 $33.37 $454K
Jan 5, 2026 MM Marianna Mancini - Officer Open-market sale Common Stock, par value $0.00001 per share 10,500 $34.22 $359K
Jan 5, 2026 MM Marianna Mancini - Officer Open-market sale Common Stock, par value $0.00001 per share 1,600 $35.07 $56K
Jan 2, 2026 MM Marianna Mancini - Officer Grant or award Stock Option (Right to Buy) 91,000 $0.00 -
Jan 2, 2026 BL Brian Lian - Officer Grant or award Common Stock, par value $0.00001 per share 78,400 $0.00 -
Jan 2, 2026 BL Brian Lian - Officer Grant or award Common Stock, par value $0.00001 per share 224,080 $0.00 -
Jan 5, 2026 BL Brian Lian - Officer Open-market sale Common Stock, par value $0.00001 per share 132,454 $32.29 $4.28M
Jan 5, 2026 BL Brian Lian - Officer Open-market sale Common Stock, par value $0.00001 per share 53,279 $33.38 $1.78M
Jan 5, 2026 BL Brian Lian - Officer Open-market sale Common Stock, par value $0.00001 per share 41,276 $34.22 $1.41M
Jan 5, 2026 BL Brian Lian - Officer Open-market sale Common Stock, par value $0.00001 per share 6,400 $35.07 $224K
Jan 2, 2026 BL Brian Lian - Officer Grant or award Stock Option (Right to Buy) 176,300 $0.00 -
Jan 2, 2026 JS J. Matthew Singleton Grant or award Common Stock, par value $0.00001 per share 3,150 $0.00 -
Jan 2, 2026 LM Lawson Macartney Grant or award Common Stock, par value $0.00001 per share 3,150 $0.00 -
Jan 2, 2026 LM Lawson Macartney Grant or award Stock Option (Right to Buy) 20,400 $0.00 -
Jan 2, 2026 MF Matthew W. Foehr Option exercise Common Stock, par value $0.00001 per share 16,000 $3.33 $53K
Jan 2, 2026 MF Matthew W. Foehr Open-market sale Common Stock, par value $0.00001 per share 16,000 $35.11 $562K
Jan 2, 2026 MF Matthew W. Foehr Grant or award Common Stock, par value $0.00001 per share 3,150 $0.00 -
Jan 2, 2026 MF Matthew W. Foehr Option exercise Stock Option (Right to Buy) 16,000 $0.00 -
Jan 2, 2026 MF Matthew W. Foehr Grant or award Stock Option (Right to Buy) 20,400 $0.00 -
Jan 2, 2026 SR Sarah Kathryn Rouan Grant or award Common Stock, par value $0.00001 per share 3,150 $0.00 -
Oct 27, 2025 CJ Charles A. Rowland Jr. Open-market sale Common Stock, par value $0.00001 per share 60,000 $35.57 $2.13M
Oct 27, 2025 GZ Greg Zante - Officer Grant or award Common Stock, par value $0.00001 per share 11,117 $0.00 -
Oct 28, 2025 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 6,185 $35.00 $216K
Oct 27, 2025 BL Brian Lian - Officer Grant or award Common Stock, par value $0.00001 per share 70,084 $0.00 -
Oct 28, 2025 BL Brian Lian - Officer Open-market sale Common Stock, par value $0.00001 per share 38,989 $35.01 $1.36M
Oct 28, 2025 MM Marianna Mancini - Officer Open-market sale Common Stock, par value $0.00001 per share 6,185 $35.00 $216K
Oct 27, 2025 MM Marianna Mancini - Officer Grant or award Common Stock, par value $0.00001 per share 11,117 $0.00 -
Jul 2, 2025 BL Brian Lian - Officer Grant or award Common Stock, par value $0.00001 per share 48,333 $0.00 -
Jul 3, 2025 BL Brian Lian - Officer Open-market sale Common Stock, par value $0.00001 per share 26,889 $27.80 $748K
Jul 2, 2025 MM Marianna Mancini - Officer Grant or award Common Stock, par value $0.00001 per share 7,667 $0.00 -
Jul 3, 2025 MM Marianna Mancini - Officer Open-market sale Common Stock, par value $0.00001 per share 4,266 $27.77 $118K
Jul 2, 2025 GZ Greg Zante - Officer Grant or award Common Stock, par value $0.00001 per share 7,667 $0.00 -
Jul 3, 2025 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 4,266 $27.76 $118K
Apr 11, 2025 MF Matthew W. Foehr Option exercise Common Stock, par value $0.00001 per share 20,786 $8.00 $166K
Apr 11, 2025 MF Matthew W. Foehr Option exercise Stock Option (Right to Buy) 20,786 $0.00 -
Nov 8, 2024 LM Lawson Macartney Option exercise Common Stock, par value $0.00001 per share 2,000 $5.80 $12K
Nov 8, 2024 LM Lawson Macartney Open-market sale Common Stock, par value $0.00001 per share 2,000 $68.67 $137K
Nov 8, 2024 LM Lawson Macartney Option exercise Stock Option (Right to Buy) 2,000 $0.00 -
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Common Stock, par value $0.00001 per share 12,750 $7.77 $99K
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Common Stock, par value $0.00001 per share 4,251 $4.68 $20K
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Common Stock, par value $0.00001 per share 26,000 $5.80 $151K
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Common Stock, par value $0.00001 per share 51,000 $8.52 $435K
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 49,672 $74.56 $3.70M
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 18,620 $75.79 $1.41M
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 9,265 $76.94 $713K
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 23,082 $77.68 $1.79M
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 15,825 $78.69 $1.25M
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 6,050 $79.78 $483K
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 7,967 $80.65 $643K
Oct 28, 2024 GZ Greg Zante - Officer Open-market sale Common Stock, par value $0.00001 per share 1,206 $81.44 $98K
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Stock Option (Right to Buy) 12,750 $0.00 -
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Stock Option (Right to Buy) 4,251 $0.00 -
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Stock Option (Right to Buy) 26,000 $0.00 -
Oct 28, 2024 GZ Greg Zante - Officer Option exercise Stock Option (Right to Buy) 51,000 $0.00 -
Oct 25, 2024 SR Sarah Kathryn Rouan Option exercise Common Stock, par value $0.00001 per share 11,000 $4.88 $54K
Oct 25, 2024 SR Sarah Kathryn Rouan Open-market sale Common Stock, par value $0.00001 per share 11,000 $80.89 $890K
Oct 25, 2024 JS J. Matthew Singleton Option exercise Common Stock, par value $0.00001 per share 16,000 $4.48 $72K
Oct 25, 2024 JS J. Matthew Singleton Open-market sale Common Stock, par value $0.00001 per share 16,000 $79.50 $1.27M
$IONS
IONIS PHARMACEUTICALS INC
